Researcher.Life Logo

Drug Resistance Updates : Impact Factor & More

eISSN: 1532-2084pISSN: 1368-7646

Key Metrics

CiteScore
30.8
Eigenfactor
0.001 - 0.005
H-Index
125
Impact Factor
20 - 25
SJR
Q1Oncology
SNIP
3.67
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Drug Resistance Updates

Drug Resistance Updates Journal Specifications

Overview
Publisher CHURCHILL LIVINGSTONE
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1998
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Drug Resistance Updates ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Drug Resistance Updates

Perineural invasion in head and neck squamous cell carcinoma: Neuro-immune mechanisms driving immunotherapy resistance and emerging therapeutic strategies.
  • 1 Jul 2026
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Interferon regulatory factor 5 associated neutrophil reprogramming by trained immunity protects against lethal-dose bacterial sepsis.
  • 1 Jul 2026
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Targeting keratin 6 A overcomes gemcitabine resistance by restoring equilibrative nucleoside transporter 1 and TAM-mediated metabolic compensation in pancreatic cancer.
  • 1 Jul 2026
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Local structural constraints and charge distribution in the protegrin-1 arginine loop govern activity against colistin-resistant Klebsiella pneumoniae.
  • 1 Jul 2026
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Breaking immune isolation in glioblastoma.
  • 6 May 2026
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Patient-derived ovarian cancer organoids as platforms for predicting platinum resistance and screening tumor stem cell inhibitors.
  • 6 May 2026
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Perineural invasion in head and neck squamous cell carcinoma: Neuro-immune mechanisms driving immunotherapy resistance and emerging therapeutic strategies.
  • 1 Jul 2026
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Interferon regulatory factor 5 associated neutrophil reprogramming by trained immunity protects against lethal-dose bacterial sepsis.
  • 1 Jul 2026
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Targeting keratin 6 A overcomes gemcitabine resistance by restoring equilibrative nucleoside transporter 1 and TAM-mediated metabolic compensation in pancreatic cancer.
  • 1 Jul 2026
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Local structural constraints and charge distribution in the protegrin-1 arginine loop govern activity against colistin-resistant Klebsiella pneumoniae.
  • 1 Jul 2026
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Breaking immune isolation in glioblastoma.
  • 6 May 2026
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Patient-derived ovarian cancer organoids as platforms for predicting platinum resistance and screening tumor stem cell inhibitors.
  • 6 May 2026
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

FAQs on Drug Resistance Updates